Genkyotex is a biopharmaceutical company that develops and commercializes NOX therapies for fibrosis, inflammation and cancer diseases.
Business Model:
Revenue: $908.2k
Employees: 11-50
Genkyotex was acquired by
Calliditas Therapeutics.
The acquisition happend on 2020-08-13.
Details of the transaction were not public
Address: Forum 2 Archamps Technopole 218 Marie Curie Avenue
City: Saint-Julien-en-Genevois
State: auvergne
Zip: 74166
Country: FR
Genkyotex is a biopharmaceutical company that develops and commercializes NOX therapies for fibrosis, inflammation and cancer diseases.
Contact Phone:
Contact Email:
Listed Exchange:
PA
IPO Date:
4/11/2014
Ticker Symbol:
Paris:GKTX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
2/2017 | Genticel |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|